Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.

A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia.

Treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone.

Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A.

Antithymocyte globulin and transplants for aplastic anemia.

Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.

Bolus methylprednisolone in severe aplastic anemia.

Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.

Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions.

[Aplastic anemia].

Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.

Indomethacin and aplastic anemia.

Acetazolamide and aplastic anemia.

Safety and efficacy of indigenous equine antithymocyte globulin along with cyclosporine in subjects with acquired aplastic anemia.

Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.

Aplastic anemia: possible associations with lymphoproliferative neoplasms.

Cyclophosphamide for aplastic anemia.

Recent advances in treatment of aplastic anemia.

Aplastic anemia associated with antithyroid drugs.

Papilledema in a patient with aplastic anemia.

First-line immunosuppressive treatment in children with aplastic anemia: rabbit antithymocyte globulin.

Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.

Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A.

Answer to "Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia".

Suggest Documents

A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia.

Treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone.

Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A.

Antithymocyte globulin and transplants for aplastic anemia.

Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.

Bolus methylprednisolone in severe aplastic anemia.

Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.

Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions.

[Aplastic anemia].

Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.

Indomethacin and aplastic anemia.

Acetazolamide and aplastic anemia.

Safety and efficacy of indigenous equine antithymocyte globulin along with cyclosporine in subjects with acquired aplastic anemia.

Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.

Aplastic anemia: possible associations with lymphoproliferative neoplasms.

Cyclophosphamide for aplastic anemia.

Recent advances in treatment of aplastic anemia.

Aplastic anemia associated with antithyroid drugs.

Papilledema in a patient with aplastic anemia.

First-line immunosuppressive treatment in children with aplastic anemia: rabbit antithymocyte globulin.

Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.

Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A.

Answer to "Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia".

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.

Recommend Documents

Follow Us